EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retinal transduction profiling of diverse AAV serotypes via intravitreal injection

Tianlu Zhang iD, Fei Wang, Yang Wu, Jingjing Cao, Yin Shen iD

Journal of Virology · 2025

DOI: 10.1128/jvi.00637-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Tianlu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Dependovirus, Retina, Transduction, Genetic, Genetic Vectors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Key Projects for Intergovernmental Coopertation in International Scientific and Technological Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimizing adeno-associated virus (AAV) capsid and dosing selection is critical for the clinical translation of retinal gene therapy. This study aims to provide a comprehensive reference by comparing the transduction efficiency, cellular tropisms, and temporal retinal expression patterns of various AAV serotypes for intravitreal retinal gene therapy. A series of AAV vectors were intravitreally injected into C57BL/6J mice. Retinal tissues were harvested 4 weeks post-injection to evaluate the transgene expression and cellular tropisms by immunostaining. Both ssAAV2.NN and scAAV2.NN vectors at a dose escalation were administered, with similar assessments conducted at 2 and 4 weeks post-injection. Additionally, the early-phase retinal transduction profiles of AAV vectors were detected at multiple time points within 12 weeks following administration. Stronger green fluorescent protein (GFP) fluorescence was observed in retinas intravitreally transduced with AAV2.NN, AAV2.GL, and AAV8 vectors, with AAV2.GL showing greater co-localization with GS + Müller cells and axons. Compared to ssAAV2.NN, scAAV2.NN vectors resulted in higher GFP fluorescence, despite similar transfected cell percentages (except for its increased co-labeling with Calbindin + horizontal cells). A dose-dependent level of GFP fluorescence was noted in scAAV2.NN vectors, with greater co-labeling with Rbpms + retinal ganglion cells at high doses. Interestingly, GFP fluorescence was detectable as early as 3 days post-injection in both ssAAV2.NN and scAAV2.NN vectors, with no prominent differences in the intensity until day 7. AAV2.GL vectors achieved higher transgene expression and broader cellular transduction via the intravitreal route. scAAV2.NN vectors presented stronger transgene expression in a dose-dependent manner. The transgene expression from both ssAAV2.NN and scAAV2.NN vectors can be detected as early as 3 days post-injection. Our study provides key insights for early-stage monitoring and vector and dosage selection in future clinical application for intravitreal gene therapy. IMPORTANCE The retinal transduction efficiency and cellular tropisms of serial AAV serotypes, including AAV2, AAV2.7m8, AAV2.NN, AAV2.GL, AAV8, AAV11, and AAV.SPR, were simultaneously and unbiasedly quantified and compared following intravitreal injection. Transgene fluorescence was detectable in cells as early as 3 days post-injection in retinas intravitreally transduced with both ssAAV2.NN and scAAV2.NN vectors. The timeliness of the onset and level of transgene expression in retinas intravitreally transduced with ssAAV2.NN and scAAV2.NN vectors were characterized during the early phase post-injection. Differences in retinal transduction efficiency and cellular tropisms of scAAV2.NN vectors at varying doses via intravitreal injection are described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusRetinaTransduction, GeneticGenetic VectorsAnimalsIntravitreal InjectionsMice, Inbred C57BLMiceSerogroupGenetic TherapyGreen Fluorescent ProteinsTransgenes

Stichwörter der Autor:innen

adeno-associated virusgene therapyintravitreal injectionretinal transduction

Substanzen

Green Fluorescent Proteins

Autor:innen und Institutionen

  • Eye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • College of Life Science and Chemistry, Hunan University of Technology, Zhuzhou, Hunan, China.
  • State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, Wuhan Center for Magnetic Resonance, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, Hubei, C…
  • Zhongmou Therapeutics, Wuhan, Hubei, China.
  • Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, Hubei, China.

ORCID-Profile: Tianlu Zhang, Yin Shen

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Key Projects for Intergovernmental Coopertation in International Scientific and Technological Innovation

Zitieren

APA

Zhang, T., Wang, F., Wu, Y., Cao, J., & Shen, Y. (2025). Retinal transduction profiling of diverse AAV serotypes via intravitreal injection. Journal of Virology. https://doi.org/10.1128/jvi.00637-25

Vancouver

Zhang T, Wang F, Wu Y, Cao J, Shen Y. Retinal transduction profiling of diverse AAV serotypes via intravitreal injection. Journal of Virology. 2025. doi:10.1128/jvi.00637-25

BibTeX
@article{Zhang2025,
  author = {Zhang, Tianlu and Wang, Fei and Wu, Yang and Cao, Jingjing and Shen, Yin},
  title = {Retinal transduction profiling of diverse AAV serotypes via intravitreal injection},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.00637-25}
}
Kostenlos starten →